(Q71573222)
Statements
The potential for normal tissue dose reduction with neoadjuvant hormonal therapy in conformal treatment planning for stage C prostate cancer (English)
Yang FE
Chen GT
Ray P
Vaida F
Chiru P
Hamilton RJ
Spelbring D
Abellera M
1 December 1995